News Releases

email   print   rss   

RSS Feeds

Quest Diagnostics to Expand Consumer Offering Through Patient-Initiated Testing Services in Colorado and Missouri
Service provides patients autonomy over their own health by allowing them to choose from diagnostic tests without a physician's order

MADISON, N.J., Nov. 21, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has launched QuestDirect, a new Patient-Initiated Testing service which will empower consumers who live in Colorado and Missouri to manage their health by ordering certain lab tests directly without a physician's order.

Quest Diagnostics Incorporated logo.

The pilot program will be available beginning today. All tests are available via an easy online ordering form that can be downloaded from Quest Diagnostics' website, QuestDiagnostics.com/QuestDirect.

"In today's consumer-driven health care environment, people want to play a more active role in managing their own health and wellness, and our Patient-Initiated Testing service is another resource for individuals to empower better health," said Steve Rusckowski, Quest Diagnostics President and CEO. "Consumers expect the most accurate and up-to-date diagnostic information to proactively manage their health so that they can make educated decisions, and we are pleased to begin offering this service to residents of Colorado and Missouri."

Customers will be able to access the results through MyQuest by Care360, used by more than three million people to see, store and share their results and health information using a smartphone, tablet or desktop computer. Prices for each test bundle are provided on the order form.

Quest's laboratories are accredited by the College of American Pathologists, the laboratory industry's gold-standard accrediting agency, a defining distinction of Quest's outstanding quality and proven testing processes.

"We are pleased to offer consumers a responsible menu of tests that will give them the insight about their health and well-being," said Cathy Doherty, senior vice president and group executive, clinical franchise solutions, Quest Diagnostics. "We believe that consumer engagement in personal health is critical and we aim to ensure consumers are connected to high quality medical care – when and where they need it."

Quest Diagnostics has been a leader in the movement for consumer empowerment in healthcare. The company has been a strong advocate of the effort to provide patients with direct access to lab testing through its joint venture partners in Arizona and Oklahoma. More than three million patients track and access their lab results and health data through Quest Diagnostics' MyQuest health portal and mobile app. The company further expanded convenient access to testing services through its recent collaboration with Safeway, offering laboratory testing services at 12 Safeway locations in 5 states. In August, Quest announced a collaboration with Ancestry.com to offer testing services on behalf of AncestryDNA.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

Quest, Quest Diagnostics and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics.

Contacts:

Quest Diagnostics
Denny Moynihan, Quest Diagnostics (Media): 973-520-2800
Shawn Bevec, Quest Diagnostics (Investors): 973-520-2900

Logo - http://photos.prnewswire.com/prnh/20150422/200883LOGO

SOURCE Quest Diagnostics